
The European Commission has approved, under EU State aid rules, three additional measures to support electricity production from renewable energy sources in Germany.
The additional measures supplement the German Renewable Energy Act (“Erneuerbare Energien Gesetz” – ‘EEG 2021′), and will further contribute to achieving Germany’s environmental targets and the EU’s strategic objectives relating to the EU Green Deal.
Executive Vice-President Margrethe Vestager, in charge of competition policy, said “The measures approved today will supplement the German Renewable Energy Act scheme which was designed tosupport environmentally-friendly electricity production, in line with EU rules. The new measures will prevent overcompensating producers in times of high electricity prices and help increase grid stability by, for example, maximising the contribution from small rooftop solar panels. These additional measures will further strengthen the objectives of the Renewable Energy Act scheme, while contributing to the reduction of greenhouse gas emissions and supporting the EU Green Deal objectives.”
Germany notified the Commission of its plans to adopt three additional measures in the context of its EEG 2021 support scheme approved by the Commission in April 2021 (SA.57779). The EEG 2021 scheme aims at increasing climate protection and expanding renewable energies. With the three additional measures, Germany committed to more market-oriented mechanisms for supporting green electricity production, offering tailored measures for different renewable energy sources.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas